Featured Insight
Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
On-Demand Webinar – SDOH and EHR – How are EHR vendors enabling providers’ efforts to close care gaps attributable to SDOH?
In this 1 hour live webinar, Precision experts Thad Nowakowski, Tim Van Aken, and Maureen Hennessey discuss the role that Social Determinants of Health plays in contributing to care gaps, current or proposed quality measures to support health equity, and how the top EHR vendors are enabling end user’s efforts to both capture SDOH variables, and act upon them to close care gaps.
On-Demand Webinar – Trends in Oncology: US Payer Management Considerations for 2022 and Beyond
In the last five years, 83 novel oncology substances have launched - oncology PMPM spend is now the highest among medical benefit categories, with 105% growth anticipated by 2024. As these numbers suggest, oncology is a key area of focus for payers, who are willing to invest resources to support appropriate utilization, but who struggle to keep up with the rapidly evolving science.
On-Demand Webinar – A Novel Data and Analytics-Informed Approach to Launch Excellence
Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.
A Focus on the Inflation Reduction Act
Curious how the healthcare provisions in the Inflation Reduction Act will impact your business? Start with this booklet by key experts from PRECISIONvalue where 5 experts weigh in on how the Inflation Reduction Act will affect payers in addition to 2023 trends, events, and developments in the payer world. Download the booklet.
White Paper: Achieving Launch Excellence: A Novel Data- and Analytics-Informed Approach
Data and analytics can help drive and inform launch preparations and support efforts to achieve launch excellence through realistic goal-setting and risk mitigation. PRECISIONadvisors works with manufacturers, helping them make key decisions—related to product positioning, go-to-market strategy, and customer engagement across payers, providers, prescribers, and patients—through data- and analytics-driven insights. Learn how an integrated data-driven approach can set realistic goals and de-risk your launch.
White Paper: 2022 and Beyond: How Key Legislative Events Will Impact the Payer Landscape
Interested in learning more about several legislative events shaping the managed care landscape in 2022 and beyond? Check out this insightful white paper, based on our recent webinar, which features insights from PRECISIONvalue’s expert Access Experience Team on various legislative proposals and payers’ potential responses to regulatory changes.
Download Now: Precision October Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision September Events Calendar
The October Events Calendar is here! Get all the details on Precision at upcoming conferences, links to upcoming and on-demand webinars, and catch up on our latest thought leadership!
Download Now: Precision June Events Calendar
The June Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
The Patient and Consumer Experience—The Core and Progress Duality for Successful and Sustainable Transformation
Over the last decade, healthcare costs have continued to rise in the United States while outcomes have been stagnant and, in some cases, declined. Implementation of strategies around patient- or consumer-driven care has been a struggle as stakeholders try to define, measure, and improve the patient experience.
Cancer Screening in Limbo: What are the Implications?
Pre-pandemic cancer death rates were trending downward at an encouraging rate. However, global instability from COVID-19 has resulted in disruption to vital cancer screenings and treatment.
White Paper: Oral Oncolytics and Oncology Care Transformation
Oral chemotherapeutic agents comprise 25% to 35% of oncology drugs in development. They are an increasingly vital component of anticancer treatment and are anticipated to play an even larger role in the longer term.
Removal of the Medicaid Rebate Cap: Sensible or Nonsense?
The American Rescue Plan of 2021 introduced a provision to remove the Medicaid Rebate Cap of 100%, effective January 2024. This legislation may turn profits upside down for a pharmaceutical company with a significant presence. Precision's Cynthia Miller discusses what it would mean to remove the Medicaid Rebate Cap, how it would affect pharmaceutical companies, and strategies for moving forward.
‘Alexa, I want to talk to a doctor’: Amazon, Teladoc partner on virtual care
In the most recent Big Tech foray into digital healthcare, Amazon and Teladoc Health announced they will be partnering on a program to provide virtual medical care. Users of Amazon’s Alexa-enabled devices will now be able to contact a doctor via voice command about non-emergency conditions on a 24/7 basis. Precision's Cynthia Miller weighs in on the benefits and shortfalls, including access problems in marginalized communities and rural areas.
On-demand Webinar- 2022 and Beyond: How Key Legislative Events will impact the payer landscape
A number of legislative events are shaping the managed care landscape in 2022. These events range from broad reaching initiatives outlined in Biden’s Build Back Better Framework to proposals for promoting adoption of biosimilars to Medicare’s Advance Notice for the 2023 benefit year and discussions around Part D re-design as well as others.
Cancer Care in the Misinformation Age
While misinformation has plagued the public health field for decades, social media has amplified its spread. Both medical and public health leaders are beginning to develop strategies for this public health crisis. Precision's Cynthia Miller lists three ways pharma companies can work with stakeholders to address cancer misinformation using evidence-based approaches.
HHS Rule Not Only Empowers Patients but Also Benefits Other Industry Stakeholders
As the use of real-world data in the health care system grows, a recent HHS rule giving patients electronic access to their data stands to have a huge impact on this area. Precision's Dominic Galante weighs in on the 21st Century Cures Act, including a discussion of stakeholders that could benefit from the rule and the potential for innovations within the health care system.
Pfizer and Takeda deals put spotlight back on value-based pricing programs
Over the last decade, value-based reimbursement models have garnered a mountain of interest, but challenges in building a data infrastructure that can identify outcome metrics and logistics to dispense payments have largely relegated these models to anecdotal status. Recent deals by Pfizer and Takeda may indicate a step forward. Precision's Ryan Cox weighs in on the evolving state of value based reimbursement models.
Treating Mental Health: Pay Now or Pay More Later
Mental health conditions, including depression and anxiety, have skyrocketed over the past two years during the pandemic. This mental health epidemic has sparked innovation among forward-looking leaders in the pharmaceutical and healthcare industries. Precision's Cynthia Miller and Maureen Hennessey look at some of the newer innovations on the horizon as well as some of the policy changes in play that will accelerate transformation.
From Cold Prospect to Healthy Relationship w/ Mike Chambers
Listen as PRECISIONvalue's Mike Chambers sits down with Ethan Beute, host of The Customer Experience Podcast, to discuss why relationship and responsiveness are at the center of customer experience, as well as other key insights regarding sales strategies.
COVID-19 and Diabetes: Strategies to Catch Up
While new diagnoses of diabetes in adults have slowed in recent years, the pandemic may reverse this trend. Physicians, payers, and pharmaceutical companies all can play a part in mitigating the long-term effects on persons with diabetes. Precision's Cynthia Miller details how these stakeholders can collaborate to mitigate future damage.
